Medical devices, healthcare technology and the business of care
PMA SUPPLEMENT · P080025/S350

InterStim Therapy System, Verify Evaluation System

Medtronic Neuromodulation · Decision date Aug 14, 2026

FDA DECISIONP080025/S350

What did the FDA decide?

FDA records P080025/S350 as a supplement to PMA P080025, with the supplement type “30-Day Notice”. The recorded decision is OK30 (30-day notice), dated Aug 14, 2026.

FDA approval order statement

implementation of manufacturing controls for Intellis rechargeable lithium-ion batteries.
Regulatory pathway
PMA supplement
Supplement type
30-Day Notice
Clinical specialty
Gastroenterology, Urology
Decision date
Aug 14, 2026
FDA change category
Process Change - Manufacturer/Sterilizer/Packager/Supplier

FDA source record

Regulatory record facts

Identifier
P080025/S350
Regulatory pathway
PMA supplement
Product code
QON
Decision code
OK30
Decision date
Aug 14, 2026
Source update
Nov 9, 2026
Original record
Open FDA source record

About this medical device

FDA device category: Implanted electrical device intended for treatment of fecal incontinence.

Product code
QON
FDA device class
3

For the original device and its historical approval scope, see PMA P080025. Subsequent supplements may change the device or its indications.

FDA decision timeline

  1. P080025 · Original PMA

    MEDTRONIC INTERSTIM SACRAL NERVE STIMULATION THERAPY SYSTEM

  2. P080025/S322 · Related supplement

    InterStim Therapy System, Verify Evaluation System

  3. P080025/S324 · Related supplement

    InterStim Therapy System, Verify Evaluation System

  4. P080025/S325 · Related supplement

    InterStim Therapy System; Verify Evaluation System

  5. P080025/S326 · Related supplement

    InterStim Therapy System, Verify Evaluation System

  6. P080025/S327 · Related supplement

    InterStim Therapy System, Verify Evaluation System

  7. P080025/S328 · Related supplement

    InterStim Therapy System; Verify Evaluation System

  8. P080025/S329 · Related supplement

    InterStim Therapy System; Verify Evaluation System

  9. P080025/S316 · Related supplement

    InterStim Therapy System

  10. P080025/S331 · Related supplement

    InterStim Therapy System, Verify Evaluation System

  11. P080025/S330 · Related supplement

    InterStim Therapy System, Verify Evaluation System (SNS Bowel Neurostimulator 97800); (SNS Bowel Neurostimulators Impl

  12. P080025/S333 · Related supplement

    InterStim Therapy System, Verify Evaluation System

  13. P080025/S321 · Related supplement

    nterStim Therapy System, Verify Evaluation System

  14. P080025/S334 · Related supplement

    InterStim Therapy System, Verify Evaluation System

  15. P080025/S336 · Related supplement

    InterStim Therapy System; Verify Evaluation System

  16. P080025/S337 · Related supplement

    InterStim Therapy System, Verify Evaluation System

  17. P080025/S338 · Related supplement

    InterStim Therapy System, Verify Evaluation System

  18. P080025/S319 · Related supplement

    InterStim TM Therapy System, Verify Evaluation System

  19. P080025/S332 · Related supplement

    InterStim Therapy System, Verify Evaluation System

  20. P080025/S339 · Related supplement

    SNS Bowel Neurostimulator Models 97800, 97810; SNS Bowel Screening Trialing System Model 3531

  21. P080025/S335 · Related supplement

    InterStim Therapy System, Verify Evaluation System (SNS Bowel Programming Systems A510, A511, A520, A521)

  22. P080025/S340 · Related supplement

    InterStim Therapy System, Verify Evaluation System

  23. P080025/S341 · Related supplement

    InterStim Therapy System, Verify Evaluation System (SNS Bowel Neurostimulator)

  24. P080025/S342 · Related supplement

    InterStim Therapy System, Verify Evaluation System (SNS Bowel Implantable Neurostimulators 97800, 97810)

  25. P080025/S344 · Related supplement

    InterStim Therapy System, Verify Evaluation System

  26. P080025/S343 · Related supplement

    InterStim Therapy System, Verify Evaluation System

  27. P080025/S345 · Related supplement

    InterStim Therapy System; Verify Evaluation System (3550-05, 3560031, 3889, 978A1, 978B1)

  28. P080025/S346 · Related supplement

    InterStim TM Therapy System; Verify Evaluation System; InterStim SNS Bowel Lead Model 978B1

  29. P080025/S347 · Related supplement

    InterStim TM Therapy System; Verify TM Evaluation System (97800)

  30. P080025/S348 · Related supplement

    InterStim Therapy System

  31. P080025/S349 · Related supplement

    InterStim Therapy System, Verify Evaluation System

  32. P080025/S350 received

    Application receipt date recorded by FDA.

  33. P080025/S350 · FDA decision

    30-Day Notice

  34. P080025/S352 · Related supplement

    InterStim Therapy System, Verify Evaluation System

  35. P080025/S351 · Related supplement

    lnterStim Therapy System, Verify Evaluation System

  36. P080025/S353 · Related supplement

    InterStim Therapy System, Verify Evaluation System

  37. P080025/S354 · Related supplement

    InterStim Therapy System, Verify Evaluation System (SNS Bowel Neurostimulator 97800), (SNS Bowel Neurostimulators Impl

Timeline entries are records held by MedtechLedger for P080025. View FDA’s full supplement list.

Related devices and submissions

Same PMA: P080025

Product / regulatory recordCompanyPathwayDecision dateSource
Medtronic NeuromodulationPMA approvalMar 14, 2011FDA
Medtronic NeuromodulationPMA supplementJul 17, 2025FDA
Medtronic NeuromodulationPMA supplementJul 17, 2025FDA
Medtronic NeuromodulationPMA supplementJul 28, 2025FDA
Medtronic NeuromodulationPMA supplementAug 1, 2025FDA
Medtronic NeuromodulationPMA supplementAug 6, 2025FDA
Medtronic NeuromodulationPMA supplementAug 28, 2025FDA
Medtronic NeuromodulationPMA supplementSep 5, 2025FDA
Medtronic NeuromodulationPMA supplementSep 10, 2025FDA
Medtronic NeuromodulationPMA supplementSep 15, 2025FDA
Medtronic NeuromodulationPMA supplementSep 18, 2025FDA
Medtronic NeuromodulationPMA supplementOct 16, 2025FDA
Medtronic NeuromodulationPMA supplementNov 4, 2025FDA
Medtronic NeuromodulationPMA supplementNov 26, 2025FDA
Medtronic NeuromodulationPMA supplementDec 22, 2025FDA
Medtronic NeuromodulationPMA supplementDec 23, 2025FDA
Medtronic NeuromodulationPMA supplementJan 14, 2026FDA
Medtronic NeuromodulationPMA supplementJan 20, 2026FDA
Medtronic NeuromodulationPMA supplementFeb 11, 2026FDA
Medtronic NeuromodulationPMA supplementFeb 12, 2026FDA
Medtronic NeuromodulationPMA supplementFeb 24, 2026FDA
Medtronic NeuromodulationPMA supplementFeb 27, 2026FDA
Medtronic NeuromodulationPMA supplementMar 18, 2026FDA
Medtronic NeuromodulationPMA supplementApr 3, 2026FDA
Medtronic NeuromodulationPMA supplementMay 1, 2026FDA
Medtronic NeuromodulationPMA supplementMay 7, 2026FDA
Medtronic NeuromodulationPMA supplementMay 22, 2026FDA
Medtronic NeuromodulationPMA supplementJun 4, 2026FDA
Medtronic NeuromodulationPMA supplementJun 5, 2026FDA
Medtronic NeuromodulationPMA supplementJun 12, 2026FDA
Medtronic NeuromodulationPMA supplementJun 16, 2026FDA
Medtronic NeuromodulationPMA supplementSep 14, 2026FDA
Medtronic NeuromodulationPMA supplementOct 6, 2026FDA
Medtronic NeuromodulationPMA supplementOct 9, 2026FDA
Medtronic NeuromodulationPMA supplementOct 29, 2026FDA

Explore the linked device profile

Other records with product code QON

Product / regulatory recordCompanyPathwayDecision dateSource
BOSTON SCIENTIFIC CORPORATIONPMA supplementAug 7, 2026FDA
BOSTON SCIENTIFIC CORPORATIONPMA supplementJul 24, 2026FDA
Axonics SNM SystemP190006/S112
BOSTON SCIENTIFIC CORPORATIONPMA supplementJun 17, 2026FDA

A shared product code identifies a classification relationship; it does not establish clinical equivalence.

Regulatory context

A PMA supplement records a change to a device with an existing premarket approval. The supplement’s approval applies to the change described in that submission.

Read our guide to FDA clearance and approval · FDA’s explanation of this pathway

Manufacturer intelligence

Medtronic Neuromodulation

Headquarters
Not reported
Brand website
medtronic.com
FDA applicant address
7000 Central Ave., NE, Ms Rcw225, Minneapolis, MN, 55432

Sources and methodology

FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.

How we use FDA records